If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
321.00    -4.00 (-1.23%)
Bid:
319.60
Ask:
321.00
Spread: 1.40 (0.438%)
Market Cap: £703.21m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Strategic Relationship with Manolete

29 Jul 2013 08:00

RNS Number : 3091K
Burford Capital
29 July 2013
 



29 July 2013

 

BURFORD ANNOUNCES STRATEGIC RELATIONSHIP WITH MANOLETE

 

Burford Capital Limited ("Burford"), the world's largest provider of investment capital and risk solutions for litigation, announces a strategic relationship with Manolete Partners PLC ("Manolete"), the UK's leading insolvency litigation financier backed by Jon Moulton.

 

Burford will make a small investment in Manolete to become a 16% shareholder, matching Moulton's ownership interest. Under the arrangement, Burford will provide co-funding of up to £10 million for Manolete's insolvency litigation investments. Manolete is also backed by Punter Southall's P-Solve business, one of the UK's leading investment advisors.

 

Please see below for the joint press release issued today, which can also be accessed via the Burford Capital website www.burfordcapital.com

 

 

 

MANOLETE PARTNERS AND BURFORD CAPITAL FORM STRATEGIC RELATIONSHIP

Jon Moulton and Punter Southall-backed insolvency financier seeing strong growth

Burford becomes shareholder in and capital provider to Manolete

Manolete Partners PLC ("Manolete"), the UK's leading insolvency litigation financier, and Burford Capital Limited ("Burford"), the world's largest provider of investment capital and risk solutions for litigation, today announced a strategic relationship that will enable Manolete to continue its strong growth as a leader in the UK insolvency litigation market and increase Burford's exposure to this specialty business.

 

Under the arrangement, Burford will become a 16% shareholder in Manolete and will provide co-funding for Manolete's insolvency litigation investments. Both Manolete and Burford are seeing strong growth in the insolvency market and Burford has initially earmarked up to £10 million for its co-funding of Manolete's investments.

 

Manolete was founded in 2009 and has enjoyed growth of more than 100% each year since its formation. Manolete is backed by Jon Moulton, one of the UK's leading private equity investors, and Punter Southall's P-Solve business, one of the UK's leading investment advisors.

 

Steven Cooklin, Manolete's founder and Managing Director, said: "When I founded Manolete in 2009, after a successful corporate finance career at HSBC, I was intrigued with the unique opportunity to apply capital to the UK insolvency litigation market. Manolete has succeeded beyond my expectations, and Burford's capital and strategic collaboration will enable us to take Manolete far beyond the next level."

 

Christopher Bogart, Burford's Chief Executive, said: "The UK insolvency litigation market is a unique environment. It is not yet subject to the Jackson reforms and it permits the direct purchase of claims. Manolete has done a superb job of developing this market and we look forward to working with Steven and his team to continue Manolete's high growth strategy."

 

Jon Moulton commented: "Manolete has been very successful since I invested. This transaction with Burford, the litigation finance market leader, reaffirms my enthusiasm for Manolete. I look forward to working closely with Steven and Chris and their teams."

 

About Manolete:

 

Manolete is the UK's leading insolvency litigation financier. Manolete buys claims direct from insolvent companies and funds individual insolvency practitioners to pursue claims in their own name. Manolete operates across the entire UK insolvency industry where clients range from the large advisory groups including PwC, Deloittes, BDO, Grant Thornton, Begbies Traynor and RSM Tenon through to smaller regional firms and boutique operators such as Wilson Field, Moorfields, Leonard Curtis and Carter Clark.

For more information about Manolete, visit www.manolete-partners.com

 

About Burford:

 

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with more than $300 million in capital and the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

For more information about Burford, visit www.burfordcapital.com

 

For further information:

 

Manolete

Steven Cooklin Tel: +(44) 1494 618520 steven@manolete-partners.com

Managing Director

Manolete Partners PLC

 

Burford press inquiries via FTI Consulting

Edward Berry Tel: +(44) 20 7269 7297 edward.berry@fticonsulting.com

Laura Ewart Tel: +(44) 20 7269 7243 laura.ewart@fticonsulting.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUWSKROOABUAR
Date   Source Headline
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.